The linked FDA records identify Becton Dickinson and Company as the legal applicant on two premarket notifications, both decided as substantially equivalent. One covers serum blood collection tubes within the clinical chemistry panel; the other covers Mueller Hinton broth culture media within microbiology. The collection also includes a recall record for a ForeSight Elite Tissue Oximetry Cable, but the enforcement excerpt does not name a recalling firm, so that record is not attributed to this applicant. [1][2][3]
Serum blood collection tubes
Filing K252344 names BD Vacutainer® Serum Blood Collection Tubes and BD Vacutainer® Rapid Serum Tubes (RST), under product code JKA and regulation number 862.1675, device class 2, in the Clinical Chemistry advisory committee. The FDA record lists the applicant as Becton, Dickinson and Company at 1 Becton Dr., Franklin Lakes, NJ, with a decision date of 2026-10-16, decision code SESE, and decision description Substantially Equivalent. The submission was received 2025-07-28, classified as Traditional clearance, with a summary statement and no third-party review. [1]
A separate FDA decision summary for K230855 describes BD Vacutainer® Serum Separator (SST™) Blood Collection Tubes as a modification of an existing device under the same regulation and product code, and states that the subject and predicate devices share the same intended use and substantially similar indications for use. That summary also reports a therapeutic drug monitoring comparison against Greiner Bio-One Vacuette® Z Serum Separator Clot Activator tubes for acetaminophen, valproic acid and vancomycin. [7][9]
An earlier decision summary for K101502 covers the BD Vacutainer® Rapid Serum Tube Blood Collection Tube with Hemogard™ Closure (BD RST HG), submitted as a new device under 21 CFR 862.1675, Class II, product code JKA, Chemistry panel, and concludes that the submitted information supports a substantial equivalence decision. [10]
Microbiology culture media
Filing K262163 names BD BBL Mueller Hinton II Broth (Cation-Adjusted) and BD Difco Mueller Hinton Broth, under product code JTZ and regulation number 866.1700, device class 2, in the Microbiology advisory committee. The FDA record lists the applicant as Becton Dickinson and Company at 7 Loveton Cir., Sparks, MD, with a decision date of 2026-09-14, decision code SESE, and decision description Substantially Equivalent. The submission was received 2026-06-26, classified as Traditional clearance, with a summary statement and no third-party review. [2]
Recall record and attribution
Recall Z-3250-2026 covers the ForeSight Elite Tissue Oximetry Cable, catalog/model HEMFSM10, UDI-DI 00690103210927, with listed part numbers and serial numbers. The record gives an Irvine, CA address, status Ongoing, recall initiation date 20260811, initial firm notification by letter, and center classification date 20260921. Distribution is described as U.S. nationwide across the listed states plus the country of Grand Cayman. [3]
The enforcement excerpt does not identify a recalling firm, so the cable is not attributed here to Becton Dickinson and Company. The supplied collection links two 510(k) records to this applicant; the recall record stands apart from those clearances and is reported only on its own terms. [3]
Collection scope
The supplied collection contains two linked records, both under the 510(k) pathway, and both carry a SESE decision, so decision counts show SESE at two. The record sample likewise contains two entries, both SESE. These figures describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1][2]


